CDNA
Caredx Inc
NASDAQ · Biotechnology
$19.47
+1.12 (+6.10%)
Open$18.72
Previous Close$18.35
Day High$19.67
Day Low$18.41
52W High$25.55
52W Low$10.96
Volume—
Avg Volume707.3K
Market Cap1.00B
P/E Ratio16.48
EPS$0.81
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+155.8% upside
Current
$19.47
$19.47
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 303.20M | 291.43M | 315.95M |
| Net Income | 47.73M | 41.29M | -68,414,801 |
| Profit Margin | 15.7% | 15.0% | -21.7% |
| EBITDA | 39.62M | 36.18M | -82,367,409 |
| Free Cash Flow | — | — | -65,793,319 |
| Rev Growth | +4.0% | +4.0% | -5.3% |
| Debt/Equity | — | — | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |